The HPAPI industry is expanding at a healthy rate due to development and manufacturing of drugs for anti-cancer and chronic disorders. Despite of challenges in designing multiproduct facilities, robust containment, safety & toxicology issues, there are many pharmaceutical firms coming up with their new research pipeline of drugs.
After our successful inaugural 2017 edition, MarketsandMarkets is proud to announce the 2nd Annual High Potent Medicines Conference to be held on 29th-30th May, 2018 in Frankfurt, Germany. The focus of this year’s conference would address the issues in process development, scale-up, regulatory updates, containment, handling, cleaning validation and toxicology of highly potent compounds. The conference would be addressing the major challenges in the HPAPI manufacturing industry where the leading industry experts will discuss the strategies for both pharma and CMO’s by presenting expert keynote presentations, live case studies and breakthrough panel sessions.
Click here to view post-show report of the High Potent Medicines Conference